Fentanyl-related deaths double in six months; US government takes some action

A new report by the US Centers for Disease Control and Prevention found that the number of overdose deaths involving the potent narcotic fentanyl and variations of the drug nearly doubled between the last half of 2016 and the first half of 2017.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

Global funding for harm reduction programs is in “crisis,” according to the latest Global State of Harm Reduction report, potentially threatening the effectiveness of HIV, hepatitis and drug overdose relief programs worldwide. Harm reduction policies and programs are meant to curb the negative effects associated with illicit drug use — such as overdoses and the spread of blood-borne illnesses like HIV and hepatitis C — rather than focusing solely on stopping substance use. Proponents, and plenty of research, suggest these practices can have a sizable impact on public health, and help drug users who ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized healthytime HIV/AIDS public health Source Type: news
Amid an opioid crisis, police and strangers with cameras are posting raw images of drug users passed out. For those whose bleakest moments now live online, life is never the same.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drug Abuse and Traffic Addiction (Psychology) Opioids and Opiates Heroin Social Media Facebook Inc YouTube.com Video Recordings, Downloads and Streaming Source Type: news
A series of data briefs from the CDC shows that life expectancy in the United States dropped for the second time in three years, with deaths from drug overdose and suicide largely responsible for the decline.
Source: AAFP News - Category: Primary Care Source Type: news
Funding Opportunity RFA-TR-19-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support intramural-extramural collaborations to develop and implement the use of 3D biofabricated tissue models as novel drug screening platforms and advance pre-clinical discovery and development of non-addictive treatments for nociception, opioid use disorder (OUD) and/or overdose. In particular, support during the UH2 phase is for the application of 3D biofabrication technologies to develop novel multicellular tissue constructs for drug screening by using human iPSC-derived cel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
Funding Opportunity RFA-TR-19-003 from the NIH Guide for Grants and Contracts. Tissue This FOA will provide funding for Investigators to create and test devices that can model the mechanisms or effects of nociception/pain-relevant signaling, addiction, or opioid use disorders (OUDs), using human tissues in in vitro microphysiological systems (MPS). Tissue chips, or microphysiological systems, are useful and promising in vitro human-based screening platforms because they closely mimic in vivo human physiology. Tissue chips have been shown to be capable of modeling normal and diseased physiology that faithfully recapitulate...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
Funding Opportunity RFA-AT-19-007 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications to expand research activities funded under RFA-AT-18-002 and RFA-DA-18-005 on the impact of interventions designed to improve adherence to Medication Assisted Treatment (MAT) or linking individuals with Opioid Use Disorders (OUD) who receive naloxone for the reversal of overdose to MAT within the context of states use of the SAMHSA Opioid STR grant funds authorized under the 21st Century Cures Act. Expansion of research activities should increase the generalizability of findings to allow for mo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
The Wisconsin Department of Health Services (DHS) today issued its first public health alert to local health departments in counties wheresuspected opioid drug overdose activity has taken place. DHS uses theNational Syndromic Surveillance Program BioSense Platform to learn about the suspected increase in activity so it can alert affected health departments. This process allows for more timely communication...(see release)
Source: Wisconsin DHFS Press Releases - Category: Hospital Management Authors: Source Type: news
A history of IV drug use or mood disorders increases overdose risk in young patients in treatment for substance abuse.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news
ConclusionsAddressing the misuse of opioids among orthopedic patients requires appropriate prescribing practices and long-term support of patients. Collaboration between surgeons and policymaking entities is recognized as an effective population-wide approach to preventing opioid dependence, misuse, and addiction.
Source: HSS Journal - Category: Orthopaedics Source Type: research
For the third year in a row, U.S. life expectancy has dropped. Overdose rates jumped by 9.6% from 2016 to 2017. Here is what Bloomberg Philanthropies'new investment will do.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
More News: Centers for Disease Control and Prevention (CDC) | Fentanyl | Government | Health | Overdose